Clinical trial Recruiting at 1 site Interventional Ages 45 and up

Improving health literacy and behaviors in older adults with hypertension in rural areas

Official title: Health Literacy and Health Promotion Behaviors Among Middle-aged and Older Adults with Hypertension in Rural Communities: a Mixed Methods Study

Run by Chimei Medical Center · NCT06666361 · Data updated 2026-11-12

This study is testing if a mobile health program can help older adults with high blood pressure in rural areas understand their condition better and adopt healthier habits.

More Hypertension trials

Quick facts

Study typeInterventional
Ages45 Years and up
SexAll
Enrollment160 (estimated)
SponsorChimei Medical Center
Academic / other
Locations1 site (Tainan, Taiwan)
StatusRecruiting
StartedDecember 7, 2024
Main results expectedDecember 31, 2025
Study endsDecember 31, 2025
Registry record updatedMarch 10, 2025
Trial IDNCT06666361 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are middle-aged and older adults aged 45 and above, diagnosed with hypertension, and capable of using a smartphone for health interventions.

Probably not a fit

Patients with cognitive impairments, mental disorders, or a high comorbidity index may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of a mobile health intervention aimed at enhancing health literacy and promoting healthy behaviors among middle-aged and older adults with hypertension in rural communities. It employs a mixed methods approach, beginning with qualitative research followed by a quantitative phase that includes a randomized controlled trial. Participants will be assigned to either an experimental group receiving a hypertension education manual along with mobile health support or a control group receiving only the manual. The intervention lasts for two months, with assessments conducted before and after the program to measure changes in health literacy and behaviors.

Why it matters

Potential benefit: If successful, this intervention could significantly improve health literacy and self-management behaviors in patients with hypertension, leading to better health outcomes.

How similar studies have gone: Other studies have shown promise in using mobile health interventions to improve health outcomes in similar populations, indicating a potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Diagnosed with hypertension for one year or more (including) and controlled with medication (systolic blood pressure ≥ 130 mmHg and diastolic blood pressure ≥ 80 mmHg).
2. Aware hypertensive patients aged ≥ 45 years with the ability to read and write.
3. Able to take medication independently.
4. Own a smartphone and are able to use it, and are willing to receive text messages (TxtM) or mobile health interventions (m-Health).
5. Agree to participate in the study.

Exclusion Criteria:

1. Have cognitive impairments or mental disorders.
2. CCI (Charlson Comorbidity Index) score ≥ 3.

Where it's running

  • Chi Mei Hospital, Liouying
    Tainan, Taiwan, Taiwan
    Recruiting

Study contacts

  • Principal investigator: Su.Chiu Hsiao — Chi Mei Medical Center,Liouying Director Nursing Department
  • Study coordinator: Man-Ting Cheng
  • Email: hate6699@gmail.com
  • Phone: +886 961062509

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.